FDA Adverse Event Death Summary report: N

NAVISTAR® THERMOCOOL®

MDR report key: 4122387 · Received September 26, 2014

Report

Report Number
2029046-2014-00338
Event Type
Death
Date Received
September 26, 2014
Date of Event
January 1, 2010
Report Date
September 16, 2014
Manufacturer
BIOSENSE WEBSTER, INC (IRWINDALE)
Product Code
LPB
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE PRODUCT WAS DISCARDED, THEREFORE NO PRODUCT FAILURE ANALYSIS CAN BE CONDUCTED AND DEVICE MALFUNCTION CANNOT BE CONFIRMED. DEVICE HISTORY RECORD (DHR) REVIEW CANNOT BE CONDUCTED BECAUSE NO LOT NUMBER WAS PROVIDED BY THE CUSTOMER. MANUFACTURER'S REF. NO: (B)(4). EVENT DESCRIPTION CONTINUATION: PER THE ARTICLE, OTHER NON-SERIOUS AE¿S WERE ALSO REPORTED: ONE PROLONGED PERICARDIAL BLEEDING AFTER EPICARDIAL ABLATION MANAGED CONSERVATIVELY. THIS EVENT IS NOT KNOWN TO HAVE REQUIRED INTERVENTION/TREATMENT NOR EXTENDED HOSPITALIZATION STAY. IF ADDITIONAL INFORMATION IS RECEIVED, WE WILL UPDATE INFORMATION IN A SUPPLEMENTAL REPORT. THERE ARE 13 DEATH EVENTS REPORTED: 1. PATIENT #1 DIED WITHIN 24 HOURS OF THE PROCEDURE, AS A RESULT OF A LOW-FLOW STATE (MANUFACTURER REFERENCE #: (B)(4)). 2. PATIENT #2 DIED WITHIN 24 HOURS OF THE PROCEDURE, AS A RESULT OF LOW FLOW AND ARRHYTHMIA RECURRENCE (STATE (MANUFACTURER REFERENCE #: (B)(4)). 3. PATIENT #3 WITH ISCHEMIC HEART DISEASE AND AN EJECTION FRACTION OF 20% DEVELOPED PULSELESS ELECTRIC ACTIVITY DURING REINTERVENTION STATE (MANUFACTURER REFERENCE #: (B)(4)). 4. PATIENT #4 DIED OF HEART FAILURE AT 10 DAYS STATE (MANUFACTURER REFERENCE #: (B)(4)). 5. PATIENT #5 DIED OF HEART FAILURE AT 6 MONTHS STATE (MANUFACTURER REFERENCE #: (B)(4)). 6. PATIENT #6 PATIENT WITHOUT AN ICD DIED SUDDENLY AT 5 WEEKS STATE (MANUFACTURER REFERENCE #: (B)(4)). 7. PATIENT #7 DIED AT 30 MONTHS OF VT STORM STATE (MANUFACTURER REFERENCE #: (B)(4)). 8. SIX OTHER PATIENTS DIED OF NONCARDIAC CAUSES UNRELATED TO THE PROCEDURE FROM 20 DAYS TO 40 MONTHS AFTER INTERVENTION. THERE ARE NO DEVICE MALFUNCTIONS REPORTED IN THE PUBLICATION. MODEL AND CATALOG NUMBER ARE NOT AVAILABLE, BUT THE SUSPECTED DEVICE IS THE NAVISTAR THERMOCOOL. OTHER BW DEVICES USED IN SOME OF THE PROCEDURES: PENTARAY AND NAVISTAR CATHETERS. THIS REPORT COVERS PATIENT #1 OF THE ARTICLE: PATIENT #1 DIED WITHIN 24 HOURS OF THE PROCEDURE, AS A RESULT OF A LOW-FLOW STATE. (B)(4).

Description of Event or Problem · 1

THIS COMPLAINT IS TO DOCUMENT PATIENT #2 (DEATH EVENT) FROM THE LITERATURE ARTICLE (MANUFACTURER REFERENCE #: (B)(4)): ARTICLE TITLE: ELIMINATION OF LOCAL ABNORMAL VENTRICULAR ACTIVITIES: A NEW END POINT FOR SUBSTRATE MODIFICATION IN PATIENTS WITH SCAR-RELATED VENTRICULAR TACHYCARDIA. PER A REPORT IN THE JOURNAL OF CIRCULATION. 2012 MAY 8;125(18):2184-96, A [MULTI/SINGLE]-CENTER [CONTROLLED/RANDOMIZED/DOUBLE-BLIND,ETC.] STUDY WAS CONDUCTED ON 70 PATIENTS, BY JAÏS P OF THE HOPITAL HAUT-LEVEQUE, BORDEAUX-PESSAC, FRANCE ET AL., TO ASSESS IF ELIMINATION OF LOCAL ABNORMAL VENTRICULAR ACTIVITIES (LAVAS) RECORDED DURING SINUS RHYTHM OR VENTRICULAR PACING WOULD BE FEASIBLE AS AN END POINT FOR VT ABLATION AND THAT COMPLETE ELIMINATION OF LAVAS WOULD LEAD TO A REDUCTION IN ARRHYTHMIA-FREE SURVIVAL. MEDIAN FOLLOW UP TIME OF 22 MONTHS. FROM THE REPORT THERE WERE 3 SERIOUS ADVERSE EVENTS: 1. ATRIAL FIBRILLATION REQUIRING ANTICOAGULATION WITH LATE DEVELOPMENT OF TAMPONADE MANAGED CONSERVATIVELY; (MANUFACTURER REFERENCE #: (B)(4)). 2. RIGHT VENTRICULAR PERFORATION REQUIRING SURGICAL REPAIR; (MANUFACTURER REFERENCE #: (B)(4)). 3. TAMPONADE DURING ENDOCARDIAL ABLATION MANAGED CONSERVATIVELY. (MANUFACTURER REFERENCE #: (B)(4)).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
600610 NAVISTAR® THERMOCOOL® SIMILAR DEVICE NI75TCJH, PMA # P030031 LPB BIOSENSE WEBSTER, INC (IRWINDALE) D-1197-00 UNKNOWN_NAVISTAR THERMO TC

Patients

Seq Age Sex Outcome Treatment
1 67 YR Death